625 related articles for article (PubMed ID: 17052420)
21. Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Pico JL; Marie JP; Chiche D; Guiguet M; Andremont A; Lapierre V; Richet H; Tancrede C; Lagrange P; Hayat M
Eur J Med; 1993 May; 2(5):275-80. PubMed ID: 8252157
[TBL] [Abstract][Full Text] [Related]
22. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
23. Bacterial infections in low-risk, febrile neutropenic patients.
Kamana M; Escalante C; Mullen CA; Frisbee-Hume S; Rolston KV
Cancer; 2005 Jul; 104(2):422-6. PubMed ID: 15937905
[TBL] [Abstract][Full Text] [Related]
24. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
25. Cefepime monotherapy for treatment of febrile neutropenia in children.
Ariffin H; Ai CL; Lee CL; Abdullah WA
J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
[TBL] [Abstract][Full Text] [Related]
26. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting.
Dommett R; Geary J; Freeman S; Hartley J; Sharland M; Davidson A; Tulloh R; Taj M; Stoneham S; Chisholm JC
Eur J Cancer; 2009 Nov; 45(16):2843-9. PubMed ID: 19616427
[TBL] [Abstract][Full Text] [Related]
27. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Koya R; Andersen J; Fernandez H; Goodman M; Spector N; Smith R; Hanlon J; Cassileth PA
Bone Marrow Transplant; 1998 May; 21(9):923-6. PubMed ID: 9613785
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of empirical antibiotic therapy in febrile neutropenic patients.
Barnes RA; Rogers TR
Br J Haematol; 1987 May; 66(1):137-40. PubMed ID: 3593650
[TBL] [Abstract][Full Text] [Related]
31. Surveillance study of bacteraemic episodes in febrile neutropenic children.
Ariffin H; Navaratnam P; Lin HP
Int J Clin Pract; 2002 May; 56(4):237-40. PubMed ID: 12074201
[TBL] [Abstract][Full Text] [Related]
32. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
[TBL] [Abstract][Full Text] [Related]
33. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
[TBL] [Abstract][Full Text] [Related]
34. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
35. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
36. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
[TBL] [Abstract][Full Text] [Related]
37. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
[TBL] [Abstract][Full Text] [Related]
38. Febrile neutropenia in haematological malignancies.
Sharma A; Lokeshwar N
J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
[TBL] [Abstract][Full Text] [Related]
39. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
[TBL] [Abstract][Full Text] [Related]
40. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
Glasmacher A; von Lilienfeld-Toal M; Schulte S; Hahn C; Schmidt-Wolf IG; Prentice A
Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():17-23. PubMed ID: 16138815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]